Transforming Voice into a Monitoring Solution
for Clinical Trials and Beyond with AI
Leading innovation in clinical trials with our vocal biomarker platform, featuring a proprietary AI-based audio processing pipeline for faster, more accurate patient screening and monitoring.
Clinical trials, while essential to advancing medical research, face challenges with efficiency and cost. Traditional processes can sometimes lead to delays in critical therapies and place added pressure on the healthcare system.
The COVID-19 pandemic highlighted opportunities to improve trial methods, with a need for more streamlined, accessible, and faster approaches.
Our AI-powered vocal biomarker platform decentralizes trials, delivering faster, more accurate patient screening and monitoring – all through the power of voice. We’re bringing next-gen efficiency and patient-centric care to clinical research.
A vocal biomarker is a characteristic or combination of features from voice data linked to clinical outcomes. They can be used to monitor patients, diagnose conditions, assess disease severity, or track treatment effectiveness.
Vocal biomarkers offer a non-invasive, cost-efficient, and scalable way to improve health monitoring and preventive care, enabling the capture of real-world patient data.
We believe healthcare should be personalised, efficient, and accessible for everyone. We aim to transform clinical research monitoring through advanced vocal biomarkers and AI, enabling seamless, real-world, remote care.
We are excited to connect and collaborate to drive groundbreaking advances in personalised, preventive care.
